Ignite Creation Date:
2025-12-24 @ 7:44 PM
Ignite Modification Date:
2026-02-24 @ 5:08 AM
Study NCT ID:
NCT03376503
Status:
COMPLETED
Last Update Posted:
2017-12-19
First Post:
2017-12-12
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Nanogen Pegfilgrastim (Pegcyte) PK/PD Clinical Study in Breast Cancer Patients
Sponsor:
Nanogen Pharmaceutical Biotechnology Joint Stock Company
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
NNG04
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None